Kim M. Keeling, Ph.D.
Affiliations: | 2000 | University of Alabama, Birmingham, Birmingham, AL, United States |
Area:
Genetics, Molecular BiologyGoogle:
"Kim Keeling"Parents
Sign in to add mentor| David M. Bedwell | grad student | 2000 | UAB | |
| (Suppression of premature stop mutations using aminoglycosides.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mangkalaphiban K, Fu L, Du M, et al. (2024) Extended stop codon context predicts nonsense codon readthrough efficiency in human cells. Nature Communications. 15: 2486 |
| Siddiqui A, Saxena A, Echols J, et al. (2023) RNA binding proteins PTBP1 and HNRNPL regulate mRNA decay. Heliyon. 9: e22281 |
| Staedtke V, Anstett K, Bedwell D, et al. (2023) Gene-targeted therapy for neurofibromatosis and schwannomatosis: The path to clinical trials. Clinical Trials (London, England). 17407745231207970 |
| Chen J, Thrasher K, Fu L, et al. (2023) The synthetic aminoglycoside ELX-02 induces readthrough of G550X-CFTR producing super-functional protein that can be further enhanced by CFTR modulators. American Journal of Physiology. Lung Cellular and Molecular Physiology |
| Siddiqui A, Dundar H, Sharma J, et al. (2023) Triamterene Functions as an Effective Nonsense Suppression Agent for MPS I-H (Hurler Syndrome). International Journal of Molecular Sciences. 24 |
| Wang D, Xue X, Gunn G, et al. (2022) Ataluren suppresses a premature termination codon in an MPS I-H mouse. Journal of Molecular Medicine (Berlin, Germany) |
| Sharma J, Du M, Wong E, et al. (2021) A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion. Nature Communications. 12: 4358 |
| Echols J, Siddiqui A, Dai Y, et al. (2020) A regulated NMD mouse model supports NMD inhibition as a viable therapeutic option to treat genetic diseases. Disease Models & Mechanisms |
| Echols J, Siddiqui A, Dai Y, et al. (2020) A regulated NMD mouse model supports NMD inhibition as a viable therapeutic option to treat genetic diseases. Disease Models & Mechanisms |
| Sharma J, Keeling KM, Rowe SM. (2020) Pharmacological approaches for targeting cystic fibrosis nonsense mutations. European Journal of Medicinal Chemistry. 200: 112436 |